Has MK4 been shown to promote and maintain healthy bones?
Yes. In clinical trials MK4 has been shown to be an important nutrient for building bone. It can build bones and decrease the risk of vertebral fracture by 60%, hip fracture by 71% and all nonvertebral fractures by 81%. In fact, 45 mg/day of MK4 has been an approved treatment for osteoporosis in Japan since 1995. In comparison, Fosamax only decreases vertebral fracture risk by about 45 percent, Actonel by about 50 percent and Boniva by 52 percent.
